Chardan Healthcare

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CHAQ and buy or sell other stocks, ETFs, and their options commission-free!

About CHAQ

Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. 

CEO
Magdalene K. Cook, MD
CEOMagdalene K. Cook, MD
Employees
Employees
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
Employees

CHAQ Key Statistics

Market cap
55.26M
Market cap55.26M
Price-Earnings ratio
-4.18
Price-Earnings ratio-4.18
Dividend yield
Dividend yield
Average volume
28.30K
Average volume28.30K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$9.74
52 Week high$9.74
52 Week low
$1.34
52 Week low$1.34

Stock Snapshot

As of today, Chardan Healthcare(CHAQ) shares are valued at $8.41. The company's market cap stands at 55.26M, with a P/E ratio of -4.18.

On 2026-07-25, Chardan Healthcare(CHAQ) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 28.3K.

The stock's 52-week range extends from a low of $1.34 to a high of $9.74.

The stock's 52-week range extends from a low of $1.34 to a high of $9.74.

People also own

Based on the portfolios of people who own CHAQ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.